NCT00385203View on ClinicalTrials.gov

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2009

Conditions

Gastrointestinal Stromal TumorsSoft Tissue Sarcomas

Interventions

DRUG

AZD2171

45 mg oral tablet once daily dose

Trial Locations (2)

Unknown

Research Site, Manchester

Research Site, Sutton

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY